General MedicationsORALGeneric
TENOFOVIR ALAFENAMIDE
TENOFOVIR ALAFENAMIDE
Standard Dose
25MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: None (Tentative Approval)
Summary
Approval overview TENOFOVIR ALAFENAMIDE is listed in Drugs@FDA under application 214072 (ANDA).
Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient TENOFOVIR ALAFENAMIDE Form and strength TABLET;ORAL - 25MG Sponsor SHILPA MEDICARE LTD Submission history Latest submission status date: 2022-09-15 00:00:00.
Structured Monograph
Clinical summary
Approval overview TENOFOVIR ALAFENAMIDE is listed in Drugs@FDA under application 214072 (ANDA). Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient TENOFOVIR ALAFENAMIDE Form and strength TABLET;ORAL - 25MG Sponsor SHILPA MEDICARE LTD Submission history Latest submission status date: 2022-09-15 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: None (Tentative Approval)
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.